LABCORP HOLDINGS INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LABCORP HOLDINGS INC. payments for repurchase of common stock for the quarter ending 2026-06-30 was $353.80M, a 76.90% increase year-over-year.
- LABCORP HOLDINGS INC. payments for repurchase of common stock for the quarter ending 2026-03-31 was $98.00M.
- LABCORP HOLDINGS INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $225.00M, a 199.60% increase year-over-year.
- LABCORP HOLDINGS INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $25.00M, a 66.67% decline year-over-year.
- LABCORP HOLDINGS INC. payments for repurchase of common stock for fiscal 2025 was $450.00M, a 79.93% increase from fiscal 2024.
- LABCORP HOLDINGS INC. payments for repurchase of common stock for fiscal 2024 was $250.10M, a 74.99% decline from fiscal 2023.
- LABCORP HOLDINGS INC. payments for repurchase of common stock for fiscal 2023 was $1.00B, a 9.09% decline from fiscal 2022.
- LABCORP HOLDINGS INC. payments for repurchase of common stock for fiscal 2022 was $1.10B, a 34.07% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $353.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $701.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $98.00M 10-Q · filed 2026-05-04 | $548.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $225.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $450.00M 10-K · filed 2026-02-24 |
| 2025-09-30 | $25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $300.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $200.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $350.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | |
| 2024-12-31 | $75.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $250.10M 10-K · filed 2026-02-24 |
| 2024-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | |
| 2023-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.00B 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.01B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | |
| 2022-12-31 | $300.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.10B 10-K · filed 2025-02-25 |
| 2022-09-30 | $800.00M 10-Q · filed 2022-11-01 | $2.20B derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | $400.00M 10-Q · filed 2022-08-01 | $1.70B derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-29 | $1.60B derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-12-31 | $1.00B 10-Q · filed 2022-11-01 | $1.67B 10-K · filed 2024-02-26 |
| 2021-09-30 | $300.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $668.50M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $300.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $368.50M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $68.50M 10-Q · filed 2022-04-29 | $68.50M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $100.00M 10-K · filed 2023-02-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $150.00M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $250.00M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $100.00M 10-Q · filed 2021-05-04 | $449.90M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $450.00M 10-K · filed 2022-02-25 |
| 2019-09-30 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $800.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $199.90M 10-Q · filed 2019-08-08 | $850.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $100.10M 10-Q · filed 2020-05-08 | $725.10M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $700.00M 10-K · filed 2021-02-25 |
| 2018-09-30 | $150.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $340.00M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $75.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $232.10M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $75.00M 10-Q · filed 2019-05-03 | $265.10M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $338.10M 10-K · filed 2020-02-28 |
| 2017-09-30 | $42.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $342.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $108.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $299.90M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $148.00M 10-Q · filed 2018-05-01 | $191.90M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $43.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $43.90M 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $0.00 10-Q · filed 2017-04-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $39.10M derived: sum of 4 quarters · filed 2016-03-01 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $104.80M derived: sum of 4 quarters · filed 2016-03-01 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-04 | $0.00 derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-12-31 | $39.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $269.00M 10-K · filed 2016-03-01 |
| 2014-09-30 | $65.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $480.00M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-06-30 | -$104.80M derived: 10-Q 6 month − 10-K 3 month · filed 2015-07-30 | $700.60M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-03-31 | $269.00M 10-K · filed 2017-02-27 | $1.17B derived: sum of 4 quarters · filed 2017-02-27 |
| 2013-12-31 | $250.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $1.02B 10-K · filed 2016-03-01 |
| 2013-09-30 | $286.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $901.50M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $365.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $743.10M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $113.90M 10-Q · filed 2014-04-29 | $508.10M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $136.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $516.50M 10-K · filed 2015-02-26 |
| 2012-09-30 | $127.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $555.60M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $130.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-30 | $573.70M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $122.30M 10-Q · filed 2013-05-01 | $503.90M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $175.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $643.90M 10-K · filed 2014-02-25 |
| 2011-09-30 | $146.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-30 | $468.80M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $60.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $444.70M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $262.30M 10-Q · filed 2012-04-27 | $500.10M derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $338.10M 10-K · filed 2013-02-26 |
| 2010-09-30 | $121.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $452.00M derived: sum of 4 quarters · filed 2012-02-24 |
| 2010-06-30 | $115.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02 | $489.20M derived: sum of 4 quarters · filed 2012-02-24 |
| 2010-03-31 | $100.30M 10-Q · filed 2011-05-04 | $373.30M derived: sum of 4 quarters · filed 2012-02-24 |
| 2009-12-31 | $113.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24 | $273.00M 10-K · filed 2012-02-24 |
| 2009-09-30 | $159.10M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-01 | $159.10M derived: sum of 4 quarters · filed 2011-03-07 |
| 2009-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-20 | $268.60M derived: sum of 4 quarters · filed 2011-03-07 |
| 2009-03-31 | $0.00 10-Q · filed 2010-04-28 | |
| 2008-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2011-03-07 | $333.60M 10-K/A · filed 2011-03-07 |
| 2008-09-30 | $268.60M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-10-29 | |
| 2007-12-31 | $921.20M 10-K · filed 2010-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |